NCT04061161View on ClinicalTrials.gov

Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD

PHASE4CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

August 19, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

COPD

Interventions

DRUG

Tiotropium Bromide

Participants will be double-blind randomized for Tiotropium or Placebo treatment for 6 weeks

Trial Locations (2)

9713 GZ

University Medical Center, Groningen

8934 AD

Medical centrum Leeuwarden, Leeuwarden

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

University Medical Center Groningen

OTHER

NCT04061161 - Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD | Biotech Hunter | Biotech Hunter